Theory of thoughts (ToM), or the capacity to attribute psychological states to oneself and others, is a core factor of social cognition (SC). Even although its significance for social functioning usually, and neurodevelopmental problems (NDDs), specifically, is nicely established, the hyperlinks between ToM and different cognitive features usually are not. Especially the familial underpinnings of such hyperlinks stay unclear.
Using a co-twin management design, we examined N = 311 twins (imply age M = 17.19 years, 47% females) recognized with autism spectrum dysfunction (ASD), consideration-deficit/hyperactivity dysfunction (ADHD), different NDDs, or sometimes growing people. We used the Reading the Mind in the Eyes Test to operationalize ToM, the Fragmented Pictures Test for central coherence (CC), the Tower Test for govt functioning (EF), and the normal capacity index in the Wechsler Intelligence Scales for IQ.
In the linear regressions, weak CC and a decrease IQ have been related to a decreased ToM capacity throughout pairs. Female intercourse and larger age have been robustly related to elevated ToM capacity, whereas EF was not related to ToM. In the inside-pair analyses, the place unmeasured familial confounders are implicitly adjusted, the associations between ToM and different cognitive features, have been attenuated and the affiliation with CC was non-important.
The end result means that familial elements shared by the twins, reminiscent of genetic and shared setting, affect the affiliation between CC, IQ, and ToM. Future research want to incorporate a bigger pattern of monozygotic twins, who’re genetically similar, with the intention to draw extra agency conclusions relating to the affect of familial elements, and to distinguish between shared environmental and genetic results on the associations between cognitive features.
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure
Ferric derisomaltose (FDI) is an intravenous (IV) excessive-dose iron formulation authorised in the US for the remedy of iron deficiency anemia in adults who’re illiberal of/have had an unsatisfactory response to oral iron, or who’ve non-dialysis-dependent continual kidney illness (NDD-CKD). FERWON-NEPHRO was a randomized, open-label, multicenter scientific trial evaluating the security and efficacy of a single infusion of FDI 1,000 mg versus as much as 5 doses of iron sucrose (IS) 200 mg (advisable cumulative dose, 1,000 mg) over eight weeks in sufferers with NDD-CKD and iron deficiency anemia. Of 1,525 sufferers included in the security evaluation, 244 (16%) had a historical past of coronary heart failure (HF).
Overall, the price of critical or extreme hypersensitivity reactions was low and didn’t differ between remedy teams. Cardiovascular hostile occasions (AEs) have been reported for 9.4% of sufferers who had HF and 4.2% who didn’t. Time to first cardiovascular AE was longer following administration of FDI in contrast with IS (hazard ratio: 0.59 [95% CI: 0.37, 0.92]; p=0.0185), a distinction that was comparable in sufferers with or with out HF (p=0.908 for interplay).
Patients achieved a sooner hematological response (assessed by adjustments in hemoglobin and ferritin concentrations, and improve in transferrin saturation) with FDI versus IS. In conclusion, in sufferers with NDD-CKD, a single infusion of FDI was secure, nicely tolerated, and was related to fewer cardiovascular AEs and a sooner hematological response, in comparison with a number of doses of IS. These results have been comparable for sufferers with and with out HF.
Further proof for de novo variants in SYNCRIP as the trigger of a neurodevelopmental dysfunction
SYNCRIP encodes for the Synaptotagmin-binding cytoplasmic RNA-interacting protein, concerned in RNA-binding and regulation of a number of mobile pathways. It has been proposed as a candidate gene for neurodevelopmental problems (NDDs) with autism spectrum dysfunction (ASD), mental incapacity (ID), and epilepsy. We ascertained genetic, scientific, and neuroradiological information of three further people with novel de novo SYNCRIP variants.
All people had ID. Autistic options have been noticed in two. One particular person confirmed myoclonic-atonic epilepsy. Neuroradiological options comprised periventricular nodular heterotopia and widening of subarachnoid areas. Two frameshift variants in the extra severely affected people, seemingly end in haploinsufficiency.
The third missense variant lies in the conserved RRM 2 area seemingly affecting RNA-binding. Our findings assist the significance of RRM domains for SYNCRIP performance and counsel genotype-phenotype correlations. Our research supplies additional proof for an SYNCRIP-related NDD characterised by ID and ASD sporadically accompanied by malformations of cortical growth and myoclonic-atonic epilepsy.
Check This One: Rat Tumor Necrosis Factor (TNF) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Rat Tumor Necrosis Factor (TNF) concentrations in serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. Get More Information: abx050220
Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease
Genetics has pushed important discoveries in the area of neurodegenerative illnesses (NDDs). An rising theme in neurodegeneration warrants an pressing and complete replace: that provider standing of early-onset autosomal recessive (AR) illness, sometimes thought-about benign, is related to an elevated threat of a spectrum of late-onset NDDs.
Glucosylceramidase beta (GBA1) gene mutations, liable for the AR lysosomal storage dysfunction Gaucher illness, are a outstanding instance of this precept, having been recognized as an necessary genetic threat issue for Parkinson illness. Genetic analyses have revealed additional examples, notably GRN, TREM2, EIF2AK3, and a number of different LSD and mitochondria perform genes.
Rabbit Polyclonal DcR2 Antibody |
|||
TA305975 | Origene Technologies GmbH | 100 µg | Ask for price |
DcR2 Rabbit Monoclonal Antibody |
|||
E10G21303 | EnoGene | 100 μl | 275 EUR |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
DcR2 (TNFRSF10D) goat polyclonal antibody |
|||
GT15063-100 | Origene Technologies GmbH | 100 µg | Ask for price |
Human DcR2/TRAIL R4 Antibody Pair Set |
|||
ABPR-ZB173 | Creative Diagnostics | 5 plates, 15 plates | Ask for price |
Description: Quantitative determination of Human DcR2/TRAIL R4 |
|||
DcR2 (TNFRSF10D) rabbit polyclonal antibody, Purified |
|||
SP1174P | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse Anti-Human DcR2/TRAIL R4 monoclonal antibody, clone NN19 |
|||
CABT-ZB595 | Creative Diagnostics | 50 μl | 456 EUR |
Description: Mouse |
|||
Mouse Anti-Human DcR2/TRAIL R4 monoclonal antibody, clone NN10 |
|||
CABT-ZB947 | Creative Diagnostics | 50 μl | 456 EUR |
Description: Mouse |
|||
DcR2 Peptide |
|||
2021P | ProSci | 0.05 mg | 197.7 EUR |
Description: (ID) DcR2 peptide |
|||
DcR2 (TNFRSF10D) (Center) rabbit polyclonal antibody, Aff - Purified |
|||
AP54308PU-N | Origene Technologies GmbH | 400 µl | Ask for price |
DcR2 (TNFRSF10D) mouse monoclonal antibody, clone B-R27, PE |
|||
AM31202RP-N | Origene Technologies GmbH | 1 ml (100 Tests) | Ask for price |
DcR2 (TNFRSF10D) mouse monoclonal antibody, clone B-R27, Purified |
|||
AM31202PU-N | Origene Technologies GmbH | 2 ml (200 Tests) | Ask for price |
DCR2 Rabbit mAb |
|||
60008 | SAB | 100ul | 339 EUR |
DcR2 Rabbit mAb |
|||
E2R24086 | EnoGene | 100ul | 255 EUR |
Description: Available in various conjugation types. |
|||
DCR2 Rabbit mAb |
|||
A3581 | Abclonal | 100μL | 778.7 EUR |
Description: Recombinant fusion protein containing a sequence corresponding to amino acids 1-165 of human RPL7A (P62424). |
|||
DcR2 Rabbit mAb |
|||
52249 | SAB | 100ul | 499 EUR |
DcR2 Rabbit mAb |
|||
E2R389166 | EnoGene | 100ul | 275 EUR |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
DcR2 (TNFRSF10D) mouse monoclonal antibody, clone B-P30, Azide Free |
|||
AM31201AF-N | Origene Technologies GmbH | 200 µg | Ask for price |
DcR2 (TNFRSF10D) mouse monoclonal antibody, clone TRAIL-R4-01, PE |
|||
AM03039RP-N | Origene Technologies GmbH | 100 µg | Ask for price |
DcR2 (TNFRSF10D) mouse monoclonal antibody, clone TRAIL-R4-01, FITC |
|||
AM03039FC-N | Origene Technologies GmbH | 100 µg | Ask for price |
DcR2 (TNFRSF10D) mouse monoclonal antibody, clone TRAIL-R4-01, Azide Free |
|||
AM03039AF-N | Origene Technologies GmbH | 100 µg | Ask for price |
Anti-DcR2 antibody |
|||
PAab02271 | Lifescience Market | 100 ug | 494.4 EUR |
Anti-DcR2 Antibody |
|||
Y080031 | ABM | 100 µl | 125 EUR |
Anti-DcR2 Antibody |
|||
2419 | Genovis AB | 100ug | 445 EUR |
DcR2 ELISA KIT|Human |
|||
EF009028 | Lifescience Market | 96 Tests | 826.8 EUR |
human Trail Receptor 4/DcR2/CD264 |
|||
M850850048 | Tecan Benelux | 1 unit | 267.03 EUR |
Human DCR2/TNFRSF10D PicoKine ELISA Kit |
|||
EK2067 | BosterBio | 96 wells | 510 EUR |
Description: For quantitative detection of human DCR2/TNFRSF10D in cell culture supernates, serum and plasma (heparin, EDTA, citrate). |
|||
Recombinant Human DcR2 Protein, Fc & His Tag |
|||
E40KMP1006 | EnoGene | 20ug | 495 EUR |
anti-DcR2 |
|||
YF-PA25185 | Abfrontier | 50 ul | 400.8 EUR |
Description: Mouse polyclonal to DcR2 |
|||
human Trail Receptor 4/DcR2/CD264 1 x 96 |
|||
M850850096 | Tecan Benelux | 1 unit | 492.85 EUR |
human Trail Receptor 4/DcR2/CD264 2 x 96 |
|||
M850850192 | Tecan Benelux | 1 unit | 791.27 EUR |
Anti-B. anthracis Protective Antigen Monoclonal antibody, Clone DCR0203 |
|||
DMABT-Z59226 | Creative Diagnostics | 1 mg | 926.1 EUR |
Description: Mouse |
|||
Active Recombinant Human TNFRSF10D/DcR2/TRAIL-R4/CD264 Protein |
|||
RP00992 | Abclonal | 10 μg | 104 EUR |
DcR3 Antibody |
|||
24071 | SAB | 100ul | 479 EUR |
DcR3 Antibody |
|||
24071-100ul | SAB | 100ul | 468 EUR |
DcR1 Antibody |
|||
24079 | SAB | 100ul | 479 EUR |
DcR1 Antibody |
|||
24079-100ul | SAB | 100ul | 468 EUR |
DcR1 Antibody |
|||
24113 | SAB | 100ul | 479 EUR |
DcR1 Antibody |
|||
24113-100ul | SAB | 100ul | 468 EUR |
DcR3 Antibody |
|||
2140-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: DcR3 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. Several novel members in the TNFR family including DR3, DR4, DR5, and DR6 were recently discovered and function as cell death receptors. Two decoy receptors, DcR1 and DcR2, were recently identified to compete with DR4 and DR5 for their ligand TRAIL binding. A novel decoy receptor was more recently discovered and designated DcR3 and TR6, respectively,. Unlike DcR1 and DcR2, DcR3 is a soluble rather than a membrane associated molecule. DcR3 binds to FasL and LIGHT and inhibits FasL and LIGHT induced apoptosis. DcR3 transcript is expressed in a number of lung and colon carcinomas and in some normal tissues. |
|||
DcR3 Antibody |
|||
2140-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: DcR3 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. Several novel members in the TNFR family including DR3, DR4, DR5, and DR6 were recently discovered and function as cell death receptors. Two decoy receptors, DcR1 and DcR2, were recently identified to compete with DR4 and DR5 for their ligand TRAIL binding. A novel decoy receptor was more recently discovered and designated DcR3 and TR6, respectively,. Unlike DcR1 and DcR2, DcR3 is a soluble rather than a membrane associated molecule. DcR3 binds to FasL and LIGHT and inhibits FasL and LIGHT induced apoptosis. DcR3 transcript is expressed in a number of lung and colon carcinomas and in some normal tissues. |
|||
DcR1 Antibody |
|||
2179-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts were expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis. |
|||
DcR1 Antibody |
|||
2179-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts were expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis. |
|||
DcR1 Antibody |
|||
2299-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts are expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis. |
|||
DcR1 Antibody |
|||
2299-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: DcR1 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family and induces apoptosis of a variety of tumor cell lines. DR4 and DR5 are the recently identified functional receptors for TRAIL. Two decoy receptors for TRAIL have been identified and designated DcR1/TRID/TRAIL-R3/LIT and DcR2/TRAIL-R4/TRUNDD. DcR1 has extracellular TRAIL-binding domain but lacks intracellular signaling domain. It is a glycophospholipid-anchored cell surface protein. DcR1 transcripts are expressed in many normal human tissues but not in most cancer cell lines. Overexpression of DcR1 did not induce apoptosis, but attenuated TRAIL-induced apoptosis. |
|||
DCR3 Antibody |
|||
E38PA6111 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
DcR3 Antibody |
|||
E300315 | EnoGene | 100ug | 275 EUR |
Description: Available in various conjugation types. |
|||
DcR1 Antibody |
|||
GWB-7FB943 | GenWay Biotech | 0.5 ml | Ask for price |
DcR3 Antibody |
|||
GWB-F69AFD | GenWay Biotech | 0.05 mg | Ask for price |
Dcr-1 Antibody |
|||
abx031117-400ul | Abbexa | 400 ul | 627.6 EUR |
Dcr-1 Antibody |
|||
abx031117-80l | Abbexa | 80 µl | 343.2 EUR |
Dcr-1 Antibody |
|||
abx031117-400l | Abbexa | 400 µl | 518.75 EUR |
Human DcR1 Antibody |
|||
33476-05111 | AssayPro | 150 ug | 215 EUR |
DcR3 Antibody (N-term) |
|||
GWB-61C15E | GenWay Biotech | 0.1 mg | Ask for price |
DcR3 Antibody / TNFRSF6B |
|||
F54535-0.08ML | NSJ Bioreagents | 0.08 ml | 140.25 EUR |
Description: This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Overexpression of this gene has been noted in gastrointestinal tract tumors, and it is located in a gene-rich cluster on chromosome 20, with other potentially tumor-related genes. Two transcript variants encoding the same isoform, but differing in the 5' UTR, have been observed for this gene. |
|||
DcR3 Antibody / TNFRSF6B |
|||
F54535-0.4ML | NSJ Bioreagents | 0.4 ml | 322.15 EUR |
Description: This gene belongs to the tumor necrosis factor receptor superfamily. The encoded protein is postulated to play a regulatory role in suppressing FasL- and LIGHT-mediated cell death. It acts as a decoy receptor that competes with death receptors for ligand binding. Overexpression of this gene has been noted in gastrointestinal tract tumors, and it is located in a gene-rich cluster on chromosome 20, with other potentially tumor-related genes. Two transcript variants encoding the same isoform, but differing in the 5' UTR, have been observed for this gene. |
|||
Polyclonal DcR3 Antibody |
|||
APR06250G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DcR3 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal DcR1 Antibody |
|||
APR06257G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DcR1 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal DcR1 Antibody |
|||
APR06270G | Leading Biology | 0.1 mg | 790.8 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DcR1 . This antibody is tested and proven to work in the following applications: |
|||
Rabbit Polyclonal DcR3 Antibody |
|||
TA306004 | Origene Technologies GmbH | 100 µg | Ask for price |
Rabbit Polyclonal DcR1 Antibody |
|||
TA306012 | Origene Technologies GmbH | 100 µg | Ask for price |
Rabbit Polyclonal DcR1 Antibody |
|||
TA306046 | Origene Technologies GmbH | 100 µg | Ask for price |
OAPB00079-100UG - DcR1 Antibody |
|||
OAPB00079-100UG | Aviva Systems Biology | 0.1mg | 389 EUR |
OAPB00113-100UG - DcR1 Antibody |
|||
OAPB00113-100UG | Aviva Systems Biology | 0.1mg | 389 EUR |
Human Decoy Receptor 3 (DcR3) Antibody |
|||
32129-05111 | AssayPro | 150 ug | 215 EUR |
Human DcR1 Antibody (Biotin Conjugate) |
|||
33476-05121 | AssayPro | 150 ug | 315 EUR |
DcR1 Polyclonal Antibody |
|||
41854 | SAB | 100ul | 319 EUR |
DcR1 Polyclonal Antibody |
|||
41854-100ul | SAB | 100ul | 302.4 EUR |
DcR1 Polyclonal Antibody |
|||
41854-50ul | SAB | 50ul | 224.4 EUR |
DcR1 Polyclonal Antibody |
|||
E041854 | EnoGene | 100μg/100μl | 255 EUR |
Description: Available in various conjugation types. |
|||
DcR3 Polyclonal Antibody |
|||
E20-71303 | EnoGene | 100ug | 225 EUR |
Description: Available in various conjugation types. |
|||
DcR1 Polyclonal Antibody |
|||
E20-75483 | EnoGene | 100ug | 225 EUR |
Description: Available in various conjugation types. |
|||
DcR1 Polyclonal Antibody |
|||
ABP53214-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of DcR1 from Human. This DcR1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DcR1 |
|||
DcR1 Polyclonal Antibody |
|||
ABP53214-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of DcR1 from Human. This DcR1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DcR1 |
|||
DcR1 Polyclonal Antibody |
|||
ABP53214-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of DcR1 from Human. This DcR1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DcR1 |
|||
DcR3 Polyclonal Antibody |
|||
ABP51153-003ml | Abbkine | 0.03ml | 189.6 EUR |
Description: A polyclonal antibody for detection of DcR3 from Human. This DcR3 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human DcR3 at AA range: 220-300 |
|||
DcR3 Polyclonal Antibody |
|||
ABP51153-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of DcR3 from Human. This DcR3 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human DcR3 at AA range: 220-300 |
|||
DcR3 Polyclonal Antibody |
|||
ABP51153-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of DcR3 from Human. This DcR3 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human DcR3 at AA range: 220-300 |
|||
DcR1 Polyclonal Antibody |
|||
E44H06925 | EnoGene | 100ul | 255 EUR |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
DcR3 Polyclonal Antibody |
|||
E44H04497 | EnoGene | 100ul | 255 EUR |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
OAAB15146-400UL - Dcr-1 Antibody - middle region |
|||
OAAB15146-400UL | Aviva Systems Biology | 400ul | 389 EUR |
DcR1 Rabbit Polyclonal Antibody |
|||
ES4213-100ul | ELK Biotech | 100ul | 124 EUR |
Description: A Rabbit Polyclonal antibody against DcR1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
DcR1 Rabbit Polyclonal Antibody |
|||
ES4213-50ul | ELK Biotech | 50ul | 74 EUR |
Description: A Rabbit Polyclonal antibody against DcR1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
DcR3 Rabbit Polyclonal Antibody |
|||
ES2152-100ul | ELK Biotech | 100ul | 124 EUR |
Description: A Rabbit Polyclonal antibody against DcR3 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
DcR3 Rabbit Polyclonal Antibody |
|||
ES2152-50ul | ELK Biotech | 50ul | 74 EUR |
Description: A Rabbit Polyclonal antibody against DcR3 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
Human Decoy Receptor 3 (DcR3) Antibody (Biotin Conjugate) |
|||
32129-05121 | AssayPro | 150 ug | 315 EUR |
DcR1 Polyclonal Conjugated Antibody |
|||
C41854 | SAB | 100ul | 476.4 EUR |
DcR1 (TNFRSF10C) goat polyclonal antibody |
|||
GT15062-100 | Origene Technologies GmbH | 100 µg | Ask for price |
Human DcR1 AssayLite™ Antibody (RPE Conjugate) |
|||
33476-05151 | AssayPro | 150 ug | 370 EUR |
Human DcR1 AssayLite™ Antibody (APC Conjugate) |
|||
33476-05161 | AssayPro | 150 ug | 370 EUR |
Human DcR1 AssayLite™ Antibody (FITC Conjugate) |
|||
33476-05141 | AssayPro | 150 ug | 370 EUR |
Human DcR1 AssayLite™ Antibody (PerCP Conjugate) |
|||
33476-05171 | AssayPro | 150 ug | 410 EUR |
dcr-1 (Center) rabbit polyclonal antibody, Purified |
|||
AP11794PU-N | Origene Technologies GmbH | 400 µl | Ask for price |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone 2B8, PE |
|||
AM01323RP-N | Origene Technologies GmbH | 100 Tests | Ask for price |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone B-D44, PE |
|||
AM31207RP-N | Origene Technologies GmbH | 1 ml (100 Tests) | Ask for price |
DcR3 (TNFRSF6B) rabbit polyclonal antibody, Aff - Purified |
|||
AP20562PU-N | Origene Technologies GmbH | 100 µg | Ask for price |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone 2B8, FITC |
|||
AM01323FC-N | Origene Technologies GmbH | 100 µg | Ask for price |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone 2B8, Purified |
|||
AM01323PU-N | Origene Technologies GmbH | 200 µg | Ask for price |
Human Decoy Receptor 3 (DcR3) AssayLite™ Antibody (RPE Conjugate) |
|||
32129-05151 | AssayPro | 150 ug | 370 EUR |
Human Decoy Receptor 3 (DcR3) AssayLite™ Antibody (APC Conjugate) |
|||
32129-05161 | AssayPro | 150 ug | 370 EUR |
DcR3 (TNFRSF6B) (N-term) rabbit polyclonal antibody, Aff - Purified |
|||
AP54313PU-N | Origene Technologies GmbH | 400 µl | Ask for price |
Human Decoy Receptor 3 (DcR3) AssayLite™ Antibody (FITC Conjugate) |
|||
32129-05141 | AssayPro | 150 ug | 370 EUR |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone B-H47, Azide Free |
|||
AM31194AF-N | Origene Technologies GmbH | 200 µg | Ask for price |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone B-D44, Azide Free |
|||
AM31207AF-N | Origene Technologies GmbH | 200 µg | Ask for price |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone TRAIL-R3-02, PE |
|||
AM03038RP-N | Origene Technologies GmbH | 100 µg | Ask for price |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone B-D44, Purified |
|||
AM31207PU-N | Origene Technologies GmbH | 2 ml (200 Tests) | Ask for price |
Human Decoy Receptor 3 (DcR3) AssayLite™ Antibody (PerCP Conjugate) |
|||
32129-05171 | AssayPro | 150 ug | 410 EUR |
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone TRAIL-R3-02, FITC |
|||
AM03038FC-N | Origene Technologies GmbH | 100 µg | Ask for price |
PE anti-human CD263 (DcR1, TRAIL-R3) |
|||
E16FHP263-025 | EnoGene | 25 tests | 498.33 EUR |
Description: Available in various conjugation types. |
|||
PE anti-human CD263 (DcR1, TRAIL-R3) |
|||
E16FHP263-100 | EnoGene | 100 tests | 1083.33 EUR |
Description: Available in various conjugation types. |
|||
DcR1 (TNFRSF10C) mouse monoclonal antibody, clone TRAIL-R3-02, Azide Free |
|||
AM03038AF-N | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse Monoclonal anti-human TNFRSF6B (DcR3) |
|||
hAP-0238 | Angio Proteomie | 100ug | 250 EUR |
Mouse Monoclonal anti-human TNFRSF6B (DcR3) |
|||
hAP-0238A | Angio Proteomie | 100ug | 250 EUR |
Rabbit Anti-Drosophila Cryptochrome (dCRY) antiserum # 1 |
|||
CRYD13-S | Alpha Diagnostics | 100 ul | 548.4 EUR |
Rabbit Anti-Drosophila Cryptochrome (dCRY) IgG # 1, aff pure |
|||
CRYD13-A | Alpha Diagnostics | 100 ug | 578.4 EUR |
Human Dcr1 homolog Drosophila DCR1(DICER1) ELISA Kit |
|||
YLA3763HU-48T | Shanghai YL Biotech | 48T | Ask for price |
Human Dcr1 homolog Drosophila DCR1(DICER1) ELISA Kit |
|||
YLA3763HU-96T | Shanghai YL Biotech | 96T | Ask for price |
DcR3 Peptide |
|||
2140P | ProSci | 0.05 mg | 197.7 EUR |
Description: (NT) DcR3 peptide |
|||
DcR1 Peptide |
|||
2179P | ProSci | 0.05 mg | 197.7 EUR |
Description: (ED) DcR1 peptide |
|||
DcR1 Peptide |
|||
2299P | ProSci | 0.05 mg | 197.7 EUR |
Description: (ED2) DcR1 peptide |
|||
DcR1 Rabbit pAb |
|||
E2252300 | EnoGene | 100ul | 225 EUR |
Description: Available in various conjugation types. |
|||
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
|||
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
In this Review, we talk about the proof supporting the strikingly distinct allele-dependent scientific phenotypes noticed in carriers of such gene mutations and its affect on the wider area of neurodegeneration.
0